SCHEMBL30890405

SCHEMBL30890405

CN[C@@H](CC1CC1)C(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1ccc(C)nc1NC2=O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 10/20 0.33
▸ F2 P00734 1/20 0.32
▸ PDF Q9HBH1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890574 0.88 NPC1 (0.37) CNR2F2PDF
SCHEMBL30890635 0.87 OTUD7B (0.32) CNR2F2
SCHEMBL27245122 0.85 CNR2 (0.32) CNR2
SCHEMBL27245146 0.85 CNR2 (0.32) CNR2
SCHEMBL30890518 0.83 CNR2 (0.31) CNR2
SCHEMBL27245098 0.81 CNR2 (0.32) CNR2
Hydrochloric Acid SCHEMBL27244640 0.81 AKR1B1 (0.33) F2
Hydrochloric Acid SCHEMBL27244661 0.81 AKR1B1 (0.33) F2
SCHEMBL30992232 0.81 CNR2 (0.31) CNR2
SCHEMBL27244983 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback